Nobel Biocare's Australian and New Zealand operations have commenced the New Year under the governance of a new Regional Director. Mr Henrik Nedoh has taken over the role following the departure of Mike Covey in late 2011.
Formerly Head of Marketing for the Asia Pacific Region and based in Hong Kong, Mr Nedoh has relocated with his family to Sydney to oversee local operations.
"Heading up a region as important to Nobel Biocare as Australia and New Zealand is both a privilege and a challenge," Mr Nedoh said. "We have a very strong customer base here, a talented team representing us and well-established programs and facilities in place.
"We also have a lot of opportunity to work with and we have to consider how we can utilise our strengths to grow our position even further. In order to do that, I believe we need to be more innovative and address the broader needs of our customers over and above the supply of products on a transactional basis.
"We see a key goal for 2012 and beyond being to transition our relationships with our customers from a supplier of products and training to an active partner in the future success of their businesses.
"Many companies heavily focus their resources on attracting new customers and whilst we have been very successful at doing that to date, today we equally want to focus on how do we make our good
"In the end, our success is solely derived from the success of our customers, so we have much to gain from this endeavour succeeding."
Originally from, Gothenburg, Sweden, Mr Nedoh came to Nobel Biocare in 2007 following a successful early career in diverse roles including sales, marketing and product management at Volvo.
In the ensuing four years, he has similarly progressed through a unique apprenticeship in the world of implant dentistry.
In 2009, he moved to Hong Kong to set-up the company's regional headquarters as a hub for the Asia Pacific.
"I was looking for my next role in the company when fate stepped in and this opportunity arose," Mr Nedoh said. "I'm looking forward to working directly with our team in Australia and New Zealand to establish much closer ties with our customers.
"As a company, we also need to revisit our strong heritage and go back to the principles that Professor Branemark holds so dearly.
"Nobel Biocare continually invests in research, development and technology to stay at the forefront of superior patient care and I believe we have the best products and we have very unique solutions.
"The vision is simple. State-of-the-art solutions in partnership with our customers to deliver greater value and quality of life to patients."